,Arm,HR,HER2,MP,pCR,Age_at_Screening,Race,menopausal_status,ethnicity
756412,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,46,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
111881,Paclitaxel + Neratinib,1,1,1,1,37,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
451816,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,43,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
243836,Paclitaxel + Neratinib,1,0,1,1,31,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
402265,Paclitaxel + Trastuzumab,1,1,0,0,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
611662,Paclitaxel + Neratinib,0,1,0,0,55,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
139137,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,54,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
685753,Paclitaxel + AMG 386,1,0,0,0,46,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
627981,Paclitaxel,0,0,0,1,64,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
108939,Paclitaxel + Neratinib,1,1,0,1,34,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
629210,Paclitaxel + Neratinib,1,0,0,0,40,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
809037,Paclitaxel,1,0,0,0,52,White,Perimenopausal (6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
107700,Paclitaxel + MK-2206 + Trastuzumab,1,1,0,0,68,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
373672,Paclitaxel,0,0,0,0,67,Black or African American,Above categories not applicable AND Age > 50,Not Hispanic or Latino
615873,Paclitaxel,0,0,1,1,48,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
607047,Paclitaxel + AMG 386,1,0,0,1,41,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
155171,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,50,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
815421,Paclitaxel + Neratinib,1,1,0,0,68,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
609897,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,47,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
605713,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,38,Black or African American,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
246134,Paclitaxel + Trastuzumab,1,1,0,0,68,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
373346,Paclitaxel + AMG 386,1,0,0,0,59,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
349225,Paclitaxel,0,0,1,0,40,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
208265,Paclitaxel + ABT 888 + Carboplatin,0,0,0,1,41,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
395076,Paclitaxel,0,0,1,1,53,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
637752,Paclitaxel + AMG 386,0,0,1,1,48,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
331192,Paclitaxel + ABT 888 + Carboplatin,1,0,1,1,42,Black or African American,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
327133,Paclitaxel,0,0,1,0,38,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
541165,Paclitaxel + Neratinib,0,0,1,0,49,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
802778,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,64,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
794428,Paclitaxel,0,0,0,0,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
625800,Paclitaxel + Neratinib,1,1,0,0,50,White,Perimenopausal (6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
422450,Paclitaxel + Neratinib,1,0,1,1,51,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
613188,Paclitaxel + AMG 386,0,0,0,0,53,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
159284,Paclitaxel,0,0,0,0,35,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
641977,Paclitaxel + AMG 386,1,0,0,0,57,Native Hawaiian or Pacific Islander,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
326433,Paclitaxel + AMG 386,0,0,1,1,39,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
539876,Paclitaxel + Ganetespib,1,0,0,0,59,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
109623,Paclitaxel + Ganetespib,1,0,0,0,44,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
153327,Paclitaxel + Pembrolizumab,0,0,1,1,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
622315,Paclitaxel + AMG 386,0,0,1,0,48,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
597873,Paclitaxel + Pembrolizumab,0,0,1,0,36,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
111646,Paclitaxel + Ganetespib,1,0,0,0,66,White,,Not Hispanic or Latino
574091,Paclitaxel + Pembrolizumab,0,0,1,1,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
515284,Paclitaxel + Ganetespib,0,0,1,0,36,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
366120,T-DM1 + Pertuzumab,1,1,1,0,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
769972,Paclitaxel + Ganitumab,1,0,0,0,45,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
494296,Paclitaxel + Pembrolizumab,1,0,0,0,50,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
918979,Paclitaxel + Ganitumab,0,0,1,0,60,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
196024,Paclitaxel + Ganetespib,0,0,1,0,67,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
221375,Paclitaxel + Ganetespib,1,0,0,0,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
845783,Paclitaxel + AMG 386,1,0,1,1,34,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
483910,Paclitaxel + Pembrolizumab,0,0,0,0,50,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
767081,T-DM1 + Pertuzumab,0,1,0,1,61,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
425173,Paclitaxel + Pembrolizumab,1,0,0,1,55,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
464547,T-DM1 + Pertuzumab,1,1,1,1,41,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
847272,Paclitaxel,0,0,1,0,51,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
255577,Paclitaxel,0,0,1,0,50,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
884011,Paclitaxel + Ganitumab,1,0,0,0,66,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
213328,Paclitaxel,0,0,1,1,32,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
949444,Paclitaxel + AMG 386,0,0,1,0,34,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
797639,Paclitaxel + MK-2206,1,0,1,0,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
264305,Paclitaxel + Ganitumab,0,0,1,1,42,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
277888,Paclitaxel + Ganitumab,1,0,0,1,48,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
753109,Paclitaxel + MK-2206,0,0,1,1,65,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
220471,Paclitaxel + Trastuzumab,0,1,1,0,50,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
494946,Paclitaxel + Pembrolizumab,0,0,1,1,51,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
326202,Paclitaxel + Pembrolizumab,1,0,1,0,45,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
266840,Paclitaxel + Trastuzumab,1,1,0,0,37,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
378885,Paclitaxel + AMG 386,1,0,0,0,36,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
873686,Paclitaxel + Pembrolizumab,1,0,0,0,60,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
916586,Paclitaxel + Ganetespib,1,0,0,0,46,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
786480,Paclitaxel + Ganetespib,1,0,1,0,41,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
456506,Paclitaxel + Pembrolizumab,1,0,0,0,47,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
452703,Paclitaxel + Ganetespib,1,0,1,0,45,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
220925,T-DM1 + Pertuzumab,0,1,1,0,37,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
120001,Paclitaxel + Neratinib,0,0,0,0,53,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
131595,Paclitaxel + AMG 386,1,0,0,0,43,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
167271,T-DM1 + Pertuzumab,1,1,0,0,33,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
166412,Paclitaxel + Trastuzumab,1,1,0,0,37,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
884266,Paclitaxel + Ganetespib,1,0,0,0,49,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
604199,Paclitaxel + MK-2206,1,0,0,0,60,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
947398,T-DM1 + Pertuzumab,1,1,0,1,44,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
689480,Paclitaxel + AMG 386,1,0,0,0,54,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
146033,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,1,53,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
564701,Paclitaxel + Ganitumab,0,0,1,0,31,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
498024,Paclitaxel + Ganetespib,0,0,1,0,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
641697,Paclitaxel + Ganetespib,1,0,1,0,26,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
672734,Paclitaxel + Ganitumab,1,0,1,0,39,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
922872,Paclitaxel,1,0,0,0,65,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
522140,Paclitaxel,1,0,0,0,55,Black or African American,Above categories not applicable AND Age > 50,Not Hispanic or Latino
413211,T-DM1 + Pertuzumab,1,1,0,0,66,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
279902,Paclitaxel + Ganetespib,1,0,0,1,42,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
638126,Paclitaxel,1,0,0,0,58,White,,
551795,Paclitaxel + Pertuzumab + Trastuzumab,0,1,1,1,40,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
306401,Paclitaxel + AMG 386,1,0,1,1,58,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
571995,Paclitaxel + AMG 386,0,0,1,0,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
506623,Paclitaxel + MK-2206,0,0,1,0,69,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
498985,Paclitaxel + AMG 386 + Trastuzumab,1,1,0,0,25,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
240035,Paclitaxel + Ganetespib,1,0,1,0,68,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
172168,Paclitaxel,0,0,1,0,40,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
104384,Paclitaxel + Pembrolizumab,1,0,1,0,42,American Indian or Alaska Native,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
828199,Paclitaxel + Neratinib,1,0,0,0,43,Black or African American,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
613961,Paclitaxel + Ganetespib,0,0,1,1,45,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
376676,Paclitaxel + Ganitumab,0,0,1,0,48,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
436371,Paclitaxel,1,0,1,0,60,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
342142,Paclitaxel + Ganetespib,0,0,1,1,54,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
554577,Paclitaxel + Ganetespib,1,0,0,0,52,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
570685,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,0,70,Black or African American,Above categories not applicable AND Age > 50,Not Hispanic or Latino
986734,Paclitaxel + Ganetespib,1,0,0,0,33,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
999264,Paclitaxel + Pertuzumab + Trastuzumab,0,1,1,1,44,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
786003,T-DM1 + Pertuzumab,1,1,1,1,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
311455,Paclitaxel,1,0,0,0,58,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
663144,Paclitaxel + Ganitumab,1,0,1,0,48,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
960029,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,0,43,Native Hawaiian or Pacific Islander,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
988665,Paclitaxel + Ganetespib,1,0,0,0,49,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
802105,Paclitaxel + Pembrolizumab,1,0,0,0,44,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
494022,T-DM1 + Pertuzumab,0,1,1,0,58,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
623569,Paclitaxel + Ganetespib,0,0,1,1,40,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
618717,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,0,29,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
493775,Paclitaxel + Ganetespib,0,0,1,1,41,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
355292,Paclitaxel + Ganetespib,1,0,1,0,36,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
708387,Paclitaxel + ABT 888 + Carboplatin,0,0,1,1,29,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
257735,Paclitaxel,0,0,1,0,48,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
625854,Paclitaxel + Pembrolizumab,0,0,1,1,51,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
229824,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,60,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
152090,Paclitaxel,1,0,1,1,30,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
735673,Paclitaxel,1,0,0,0,44,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
460642,Paclitaxel + Ganitumab,1,0,0,0,45,White,,Not Hispanic or Latino
515281,Paclitaxel + Ganitumab,1,0,0,0,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
414844,Paclitaxel,1,0,1,0,51,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
851180,Paclitaxel + Neratinib,1,1,0,0,50,White,Above categories not applicable AND Age > 50,Hispanic or Latino
848003,Paclitaxel + AMG 386,0,0,1,0,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
131961,T-DM1 + Pertuzumab,1,1,0,1,44,White,,Not Hispanic or Latino
795996,Paclitaxel + Pertuzumab + Trastuzumab,1,1,1,1,47,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
683457,Paclitaxel + Ganitumab,0,0,1,0,50,Black or African American,,Not Hispanic or Latino
767934,Paclitaxel,0,0,1,1,68,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
587388,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,52,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
105513,Paclitaxel + AMG 386,1,0,1,1,48,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
277848,Paclitaxel + Neratinib,1,1,0,0,66,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
543795,Paclitaxel + Pembrolizumab,1,0,0,0,47,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
122579,Paclitaxel,1,0,0,0,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
518000,Paclitaxel + MK-2206,0,0,1,0,34,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
501303,Paclitaxel + Trastuzumab,0,1,1,1,47,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
139973,Paclitaxel,1,0,0,0,41,White,,Not Hispanic or Latino
778527,Paclitaxel + MK-2206,0,0,1,1,44,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
345907,Paclitaxel + MK-2206,0,0,1,0,61,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
963604,Paclitaxel + AMG 386,1,0,0,0,51,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
571276,Paclitaxel + Ganetespib,0,0,1,0,48,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
861745,Paclitaxel + MK-2206,1,0,1,0,31,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
517446,Paclitaxel,1,0,0,0,63,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
528479,Paclitaxel + Ganetespib,0,0,0,0,63,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
431061,Paclitaxel + Pembrolizumab,1,0,1,0,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
168044,Paclitaxel + Pembrolizumab,1,0,0,0,64,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
227832,Paclitaxel + Neratinib,1,1,0,0,53,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
860901,Paclitaxel + AMG 386,0,0,1,1,49,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
724384,Paclitaxel,1,0,0,0,43,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
621179,Paclitaxel + AMG 386,1,0,0,0,53,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
568953,Paclitaxel + AMG 386,1,0,0,0,59,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
779739,Paclitaxel + MK-2206 + Trastuzumab,1,1,0,1,47,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
863161,Paclitaxel + MK-2206 + Trastuzumab,0,1,0,1,55,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
247641,Paclitaxel,0,0,1,0,63,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
495440,Paclitaxel,1,0,0,0,49,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
679787,Paclitaxel,0,0,1,0,33,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
910188,Paclitaxel + Ganitumab,1,0,0,0,64,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
141782,Paclitaxel + Trastuzumab,1,1,0,0,54,White,Perimenopausal (6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
401215,Paclitaxel + Ganetespib,1,0,0,0,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
981664,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,1,50,Black or African American,Above categories not applicable AND Age > 50,Not Hispanic or Latino
683173,Paclitaxel + Pembrolizumab,1,0,0,1,51,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
102011,Paclitaxel + Ganetespib,1,0,1,1,32,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
703401,Paclitaxel,1,0,0,0,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
664658,Paclitaxel + Pembrolizumab,1,0,0,1,39,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
345460,Paclitaxel + Ganitumab,1,0,1,0,45,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
999733,Paclitaxel + MK-2206,1,0,0,0,47,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
689188,Paclitaxel + Ganetespib,1,0,1,1,72,Black or African American,Above categories not applicable AND Age > 50,Not Hispanic or Latino
285339,Paclitaxel + Pertuzumab + Trastuzumab,0,1,1,1,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
572793,Paclitaxel + MK-2206,0,0,1,0,49,White,,Hispanic or Latino
164468,Paclitaxel + Ganetespib,0,0,1,0,45,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
473365,Paclitaxel + Pembrolizumab,1,0,0,0,63,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
843554,Paclitaxel,0,0,1,0,31,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
467622,Paclitaxel + Ganitumab,1,0,1,0,42,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
483667,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,0,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
798604,Paclitaxel + Ganitumab,0,0,1,1,55,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
890372,Paclitaxel + Ganitumab,0,0,0,0,39,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
208650,T-DM1 + Pertuzumab,1,1,0,0,39,White,,Not Hispanic or Latino
532183,Paclitaxel,0,0,1,0,47,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
432114,Paclitaxel + Pertuzumab + Trastuzumab,1,1,1,1,50,White,,Not Hispanic or Latino
804233,Paclitaxel + Pembrolizumab,0,0,1,1,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
474874,Paclitaxel + Pertuzumab + Trastuzumab,0,1,0,1,41,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
651145,Paclitaxel + MK-2206,1,0,0,0,63,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
614434,Paclitaxel + MK-2206 + Trastuzumab,1,1,0,1,56,White,Above categories not applicable AND Age < 50,Hispanic or Latino
521860,Paclitaxel + AMG 386,0,0,1,0,35,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
215932,Paclitaxel + AMG 386 + Trastuzumab,0,1,1,0,43,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
793155,Paclitaxel + MK-2206,1,0,1,0,58,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
484894,Paclitaxel,1,0,0,0,31,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
242370,Paclitaxel + Pembrolizumab,1,0,0,1,38,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
273691,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,1,46,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
618240,Paclitaxel + AMG 386,0,0,1,0,35,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
490805,T-DM1 + Pertuzumab,1,1,0,1,42,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
250274,T-DM1 + Pertuzumab,1,1,0,0,43,Asian,Above categories not applicable AND Age < 50,Not Hispanic or Latino
239910,Paclitaxel + Ganitumab,0,0,1,0,42,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
356399,Paclitaxel,1,0,1,0,30,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
972307,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,47,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
540539,Paclitaxel + ABT 888 + Carboplatin,0,0,1,1,35,Black or African American,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
294265,Paclitaxel + MK-2206,0,0,1,1,52,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
891645,Paclitaxel + Neratinib,0,1,0,0,37,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
527581,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,0,35,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
371528,Paclitaxel + Pembrolizumab,1,0,0,0,70,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
410083,T-DM1 + Pertuzumab,0,1,0,1,55,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
199960,Paclitaxel + AMG 386,0,0,1,0,33,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
227055,Paclitaxel + AMG 386 + Trastuzumab,1,1,1,0,40,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
830486,Paclitaxel + Ganetespib,0,0,1,0,36,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
786753,Paclitaxel + MK-2206 + Trastuzumab,0,1,0,0,59,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
253531,T-DM1 + Pertuzumab,1,1,0,1,59,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
510543,Paclitaxel + Ganetespib,1,0,1,0,62,White,,Not Hispanic or Latino
591180,Paclitaxel + Neratinib,0,0,1,0,57,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
766301,Paclitaxel + AMG 386,1,0,0,0,49,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
590299,Paclitaxel + AMG 386,0,0,1,0,44,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
580541,Paclitaxel,1,0,0,0,61,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
690410,Paclitaxel + Ganetespib,1,0,0,0,69,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
654064,Paclitaxel + MK-2206,1,0,0,0,34,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
614044,Paclitaxel,0,0,0,0,52,Black or African American,Above categories not applicable AND Age > 50,Not Hispanic or Latino
791321,Paclitaxel + MK-2206,0,0,1,0,31,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
284355,Paclitaxel + ABT 888 + Carboplatin,0,0,1,0,41,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
422454,Paclitaxel + MK-2206,1,0,0,0,45,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
213672,Paclitaxel + Ganetespib,1,0,0,0,39,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
550421,Paclitaxel + Ganetespib,0,0,1,0,49,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
929391,Paclitaxel,0,0,1,0,65,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
477994,Paclitaxel + MK-2206 + Trastuzumab,1,1,1,1,54,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
119928,Paclitaxel + Ganetespib,0,0,1,0,39,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
913527,Paclitaxel,0,0,1,0,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
259899,Paclitaxel,0,0,1,0,41,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
676630,Paclitaxel + Ganitumab,0,0,1,1,42,White,Above categories not applicable AND Age < 50,Hispanic or Latino
894673,Paclitaxel + MK-2206 + Trastuzumab,1,1,0,0,59,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
622688,Paclitaxel + Pembrolizumab,0,0,1,1,29,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
870077,Paclitaxel + Ganitumab,1,0,0,0,60,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
866660,Paclitaxel,1,0,0,0,38,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
177795,Paclitaxel + Pembrolizumab,0,0,1,1,58,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
685795,Paclitaxel + AMG 386 + Trastuzumab,1,1,0,0,64,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
218503,Paclitaxel + MK-2206,1,0,0,0,52,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
802308,Paclitaxel + Ganitumab,0,0,1,0,52,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
741535,Paclitaxel,1,0,0,0,33,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
550157,Paclitaxel,0,0,1,1,63,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
362150,Paclitaxel + Ganitumab,1,0,1,0,44,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
317402,Paclitaxel + MK-2206,1,0,0,0,53,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
188700,Paclitaxel + Ganitumab,0,0,1,1,58,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
547892,Paclitaxel + Ganitumab,1,0,0,0,48,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
738041,Paclitaxel + Pertuzumab + Trastuzumab,1,1,1,1,37,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
658541,Paclitaxel,1,0,1,0,64,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
900959,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,0,63,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
130892,Paclitaxel + MK-2206,1,0,1,1,50,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
893874,Paclitaxel + Ganetespib,0,0,1,1,37,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
618860,Paclitaxel + Ganitumab,1,0,1,0,48,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
628788,Paclitaxel + Ganitumab,0,0,1,0,32,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
504838,Paclitaxel,0,0,0,0,69,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
794128,Paclitaxel + Ganitumab,0,0,0,0,44,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
882553,Paclitaxel + AMG 386,1,0,0,0,47,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
732137,Paclitaxel + MK-2206,0,0,1,0,54,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
332655,Paclitaxel + MK-2206,0,0,1,1,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
845147,Paclitaxel + MK-2206,1,0,0,0,46,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
122287,T-DM1 + Pertuzumab,1,1,1,1,54,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
535415,Paclitaxel + MK-2206 + Trastuzumab,0,1,0,1,56,White,Above categories not applicable AND Age > 50,Hispanic or Latino
851223,Paclitaxel + AMG 386,1,0,1,0,36,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
391942,Paclitaxel + Pembrolizumab,0,0,1,1,54,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
342959,Paclitaxel + MK-2206,0,0,0,1,60,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
518576,Paclitaxel + Ganetespib,0,0,0,1,50,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
971492,Paclitaxel + AMG 386,1,0,1,0,32,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
269899,Paclitaxel + Ganetespib,1,0,0,1,58,White,,Not Hispanic or Latino
894491,Paclitaxel + ABT 888 + Carboplatin,1,0,1,0,49,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
489194,Paclitaxel + Pembrolizumab,1,0,1,1,33,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
300724,Paclitaxel,1,0,0,0,59,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
674897,Paclitaxel,0,0,1,0,50,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
729732,Paclitaxel + MK-2206,1,0,0,0,36,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
635632,Paclitaxel + MK-2206 + Trastuzumab,0,1,0,1,46,Asian,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
509012,Paclitaxel + Ganitumab,0,0,1,1,52,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
991818,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,1,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
290413,Paclitaxel + AMG 386 + Trastuzumab,1,1,0,0,59,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
319324,Paclitaxel + MK-2206 + Trastuzumab,1,1,0,0,48,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
157270,Paclitaxel + AMG 386 + Trastuzumab,1,1,0,0,43,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
748611,Paclitaxel,1,0,1,1,59,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
689076,Paclitaxel,1,0,0,0,32,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
587604,Paclitaxel,0,0,1,0,45,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
943879,Paclitaxel + Ganetespib,0,0,1,1,40,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
601489,Paclitaxel + MK-2206 + Trastuzumab,0,1,1,0,54,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
917762,Paclitaxel + Ganitumab,1,0,0,0,35,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
516834,Paclitaxel + Ganitumab,1,0,0,0,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
567201,Paclitaxel + Ganetespib,0,0,1,1,47,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
607843,Paclitaxel,1,0,0,0,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
318407,Paclitaxel + Ganitumab,0,0,1,0,58,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
233962,Paclitaxel + Neratinib,0,0,1,1,33,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
473505,Paclitaxel + Pembrolizumab,1,0,1,0,56,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
689452,Paclitaxel,0,0,1,0,63,White,,Not Hispanic or Latino
935460,Paclitaxel,0,0,1,0,65,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
712917,Paclitaxel + Ganetespib,0,0,1,1,45,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
609151,Paclitaxel + MK-2206 + Trastuzumab,0,1,1,1,40,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
552313,Paclitaxel + Neratinib,0,1,1,1,61,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
181442,Paclitaxel,0,0,1,0,63,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
145777,Paclitaxel + Ganitumab,1,0,0,0,30,Asian,Above categories not applicable AND Age < 50,Not Hispanic or Latino
254060,Paclitaxel + AMG 386,0,0,1,1,38,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
411806,Paclitaxel + Ganetespib,1,0,0,0,45,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
491779,T-DM1 + Pertuzumab,1,1,1,1,70,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
575457,Paclitaxel + Pertuzumab + Trastuzumab,0,1,1,1,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
180663,Paclitaxel + MK-2206,1,0,1,0,39,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
896939,Paclitaxel + Pembrolizumab,1,0,0,0,63,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
415039,Paclitaxel + Neratinib,1,1,0,0,50,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
138425,T-DM1 + Pertuzumab,0,1,1,1,62,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
783771,Paclitaxel,1,0,1,0,31,Black or African American,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
293142,Paclitaxel,1,0,0,0,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
706639,Paclitaxel,0,0,1,0,50,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
930853,Paclitaxel + AMG 386,1,0,0,1,45,Native Hawaiian or Other Pacific Islande,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
303685,Paclitaxel + Pembrolizumab,1,0,1,1,71,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
930172,Paclitaxel + Neratinib,1,1,0,0,44,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
289107,Paclitaxel + Pembrolizumab,0,0,1,1,50,American Indian or Alaska Native,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
563681,Paclitaxel + Ganitumab,1,0,1,0,23,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
848371,Paclitaxel + Pembrolizumab,0,0,1,1,32,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
960490,Paclitaxel + Pembrolizumab,0,0,1,1,36,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
810965,Paclitaxel + Ganetespib,0,0,1,1,66,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
409288,Paclitaxel,0,0,1,0,77,Black or African American,,Not Hispanic or Latino
208303,Paclitaxel + Ganetespib,0,0,1,1,64,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
282777,Paclitaxel + Ganetespib,1,0,0,0,48,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
774840,Paclitaxel + Ganitumab,0,0,1,1,56,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
301665,Paclitaxel + AMG 386 + Trastuzumab,1,1,0,0,52,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
930903,Paclitaxel + Ganetespib,1,0,1,0,34,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
489973,Paclitaxel + AMG 386,0,0,1,0,39,Black or African American,Above categories not applicable AND Age < 50,Not Hispanic or Latino
714205,Paclitaxel + ABT 888 + Carboplatin,0,0,1,1,68,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
635862,Paclitaxel + AMG 386,0,0,1,0,37,"Asian,White",Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
783427,Paclitaxel,1,0,1,1,34,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
519738,Paclitaxel + Neratinib,0,1,0,1,58,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
831848,T-DM1 + Pertuzumab,0,1,1,1,38,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
323721,Paclitaxel + MK-2206,1,0,0,0,65,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
275626,Paclitaxel + AMG 386,0,0,1,1,42,Native Hawaiian or Pacific Islander;White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
296123,Paclitaxel + Ganitumab,0,0,1,1,62,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
237158,Paclitaxel + AMG 386,1,0,1,1,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
906795,Paclitaxel + Trastuzumab,1,1,1,0,29,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
212307,Paclitaxel + Ganitumab,1,0,0,0,34,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
229328,Paclitaxel + Ganitumab,1,0,0,0,39,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
333145,Paclitaxel + Pembrolizumab,1,0,1,1,49,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
912836,Paclitaxel + Ganetespib,0,0,1,0,57,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
327917,Paclitaxel + Ganitumab,0,0,1,0,56,Black or African American,Above categories not applicable AND Age > 50,Not Hispanic or Latino
887594,Paclitaxel + MK-2206,0,0,1,1,39,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
661730,Paclitaxel + AMG 386,0,0,1,1,39,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
572016,Paclitaxel + Ganetespib,0,0,1,1,42,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
156163,Paclitaxel + AMG 386,1,0,0,0,47,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
202535,Paclitaxel + AMG 386 + Trastuzumab,1,1,0,0,32,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
478055,Paclitaxel,1,0,0,0,31,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
347516,Paclitaxel + Pembrolizumab,0,0,1,0,39,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
399478,Paclitaxel + AMG 386,0,0,1,1,54,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
418593,Paclitaxel,1,0,0,0,32,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
395249,Paclitaxel + Ganetespib,0,0,1,0,68,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
369040,Paclitaxel,1,0,0,0,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
759418,Paclitaxel + Ganetespib,1,0,0,0,42,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
200222,Paclitaxel + MK-2206,1,0,0,0,70,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
651401,Paclitaxel + Pembrolizumab,0,0,1,0,37,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
924812,Paclitaxel + AMG 386,0,0,0,0,60,White,,Hispanic or Latino
555214,Paclitaxel + AMG 386 + Trastuzumab,0,1,1,1,49,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
296841,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,1,65,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
604380,Paclitaxel + ABT 888 + Carboplatin,0,0,1,1,52,Black or African American,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
683896,Paclitaxel + AMG 386,1,0,0,0,61,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
356431,T-DM1 + Pertuzumab,0,1,1,1,48,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
879224,Paclitaxel,0,0,0,0,33,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
752469,Paclitaxel,0,0,1,0,55,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
116603,Paclitaxel,0,0,1,0,39,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
664111,Paclitaxel + MK-2206,0,0,1,1,49,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
973837,Paclitaxel + Ganitumab,1,0,0,0,47,Asian,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
760901,Paclitaxel + Ganitumab,0,0,1,1,44,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
165925,Paclitaxel + Ganitumab,0,0,1,0,50,Black or African American,Above categories not applicable AND Age < 50,Not Hispanic or Latino
313243,Paclitaxel,1,0,1,1,36,White,,Not Hispanic or Latino
701790,Paclitaxel + Pembrolizumab,1,0,0,0,65,American Indian or Alaska Native,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
375455,Paclitaxel + Trastuzumab,1,1,0,0,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
899381,Paclitaxel,1,0,1,1,45,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
430441,Paclitaxel + Ganitumab,1,0,0,0,30,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
329941,T-DM1 + Pertuzumab,1,1,0,1,47,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
820348,Paclitaxel,1,0,1,0,33,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
748583,Paclitaxel + MK-2206,1,0,0,0,67,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
218249,Paclitaxel,1,0,0,0,59,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
655703,Paclitaxel + AMG 386,1,0,0,0,64,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
201831,Paclitaxel + AMG 386,0,0,1,1,44,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
938719,Paclitaxel,1,0,1,0,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
728287,Paclitaxel + AMG 386 + Trastuzumab,1,1,0,1,66,White,,Not Hispanic or Latino
687733,Paclitaxel + Ganetespib,1,0,0,0,43,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
646233,Paclitaxel + AMG 386,1,0,0,0,58,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
831702,T-DM1 + Pertuzumab,1,1,0,0,42,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
275034,Paclitaxel + AMG 386 + Trastuzumab,1,1,1,1,27,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
219545,Paclitaxel,0,0,1,0,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
367682,Paclitaxel,0,0,1,0,55,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
982086,Paclitaxel + Pertuzumab + Trastuzumab,0,1,1,1,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
102212,Paclitaxel + MK-2206,0,0,0,0,26,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
616994,Paclitaxel,1,0,1,0,43,Black or African American,Above categories not applicable AND Age < 50,Not Hispanic or Latino
108969,Paclitaxel + Neratinib,0,1,0,1,64,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
721099,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,0,47,White,,Hispanic or Latino
397505,T-DM1 + Pertuzumab,1,1,1,1,41,White,,Hispanic or Latino
268937,T-DM1 + Pertuzumab,1,1,0,1,50,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
109874,Paclitaxel + AMG 386,0,0,1,1,43,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
473468,Paclitaxel + Ganetespib,0,0,1,0,54,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
950742,Paclitaxel + Ganitumab,1,0,0,0,40,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
896852,T-DM1 + Pertuzumab,1,1,0,0,41,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
535569,T-DM1 + Pertuzumab,0,1,1,0,50,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
965265,Paclitaxel + AMG 386,0,0,1,0,48,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
153880,Paclitaxel + Trastuzumab,1,1,0,0,39,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
992609,Paclitaxel + AMG 386,0,0,1,1,54,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
653927,Paclitaxel,0,0,1,1,38,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
676365,Paclitaxel + Ganetespib,0,0,1,0,31,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
458196,Paclitaxel,1,0,0,0,46,Asian,,Not Hispanic or Latino
423979,Paclitaxel,1,0,0,0,54,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
318293,Paclitaxel + AMG 386,1,0,0,0,47,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
150547,Paclitaxel + Ganetespib,1,0,1,0,51,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
111344,Paclitaxel + AMG 386,1,0,1,0,55,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
849605,Paclitaxel + Neratinib,0,0,1,0,33,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
797499,T-DM1 + Pertuzumab,0,1,1,1,52,Black or African American,Above categories not applicable AND Age > 50,Not Hispanic or Latino
639663,Paclitaxel + MK-2206,0,0,1,0,30,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
768214,Paclitaxel + AMG 386,0,0,1,0,51,White,,Not Hispanic or Latino
294739,Paclitaxel,1,0,1,0,42,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
691753,Paclitaxel + Ganitumab,1,0,0,0,49,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
539904,Paclitaxel + Trastuzumab,1,1,0,0,45,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
453596,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,1,57,White,,Not Hispanic or Latino
997702,Paclitaxel + ABT 888 + Carboplatin,0,0,1,1,31,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
118307,Paclitaxel + AMG 386,0,0,1,0,44,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
706943,Paclitaxel + Neratinib,0,1,1,0,52,Black or African American,,Not Hispanic or Latino
591079,Paclitaxel + Ganetespib,0,0,1,1,43,White,Above categories not applicable AND Age < 50,Hispanic or Latino
825363,Paclitaxel + Pertuzumab + Trastuzumab,0,1,1,1,29,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
955035,Paclitaxel + Ganitumab,0,0,1,0,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
726091,Paclitaxel + Neratinib,0,0,1,1,43,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
179568,Paclitaxel + AMG 386,1,0,1,0,52,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
280375,Paclitaxel + Ganitumab,0,0,1,0,57,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
668752,Paclitaxel + Pembrolizumab,0,0,1,0,58,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
568331,Paclitaxel + AMG 386,0,0,0,0,51,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
924895,Paclitaxel + Ganetespib,1,0,0,0,39,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
125418,Paclitaxel + Ganetespib,1,0,0,0,49,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
348009,Paclitaxel + ABT 888 + Carboplatin,0,0,1,0,37,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
719713,Paclitaxel + Ganetespib,1,0,0,0,38,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
160120,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,55,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
596079,Paclitaxel + Trastuzumab,0,1,0,1,65,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
706169,Paclitaxel,0,0,1,0,70,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
920479,Paclitaxel + Neratinib,0,1,0,0,45,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
789497,Paclitaxel + AMG 386,1,0,0,0,54,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
282644,Paclitaxel + Neratinib,1,1,0,0,62,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
484867,Paclitaxel + Neratinib,1,1,0,0,51,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
564234,Paclitaxel + ABT 888 + Carboplatin,0,0,1,1,33,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
342996,Paclitaxel,1,0,0,0,42,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
760011,T-DM1 + Pertuzumab,1,1,0,1,49,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
139771,Paclitaxel + Neratinib,0,0,1,1,55,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
221686,Paclitaxel + Ganitumab,0,0,1,1,47,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
355942,Paclitaxel,1,0,0,0,52,White,,Not Hispanic or Latino
104268,Paclitaxel,0,0,1,0,50,Black or African American,Above categories not applicable AND Age > 50,Not Hispanic or Latino
116165,Paclitaxel + Pembrolizumab,1,0,0,0,55,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
420523,Paclitaxel + Neratinib,1,1,0,0,39,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
654956,Paclitaxel + Neratinib,0,1,1,0,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
145513,Paclitaxel + MK-2206 + Trastuzumab,1,1,0,0,32,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
780272,Paclitaxel + Ganitumab,0,0,1,0,54,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
419590,Paclitaxel + Ganetespib,0,0,1,0,63,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
800447,Paclitaxel + Ganitumab,0,0,1,1,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
924868,Paclitaxel + Ganetespib,0,0,1,1,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
335536,Paclitaxel + AMG 386,1,0,0,0,67,Black or African American,Above categories not applicable AND Age > 50,Not Hispanic or Latino
957408,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,29,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
125130,T-DM1 + Pertuzumab,0,1,1,1,48,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
520258,Paclitaxel,1,0,1,0,37,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
876511,Paclitaxel + Neratinib,0,0,1,0,39,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
872188,Paclitaxel + Neratinib,0,1,0,1,60,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
388581,Paclitaxel + Neratinib,1,1,0,1,48,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
402384,Paclitaxel + MK-2206,0,0,1,0,59,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
833536,Paclitaxel + ABT 888 + Carboplatin,0,0,0,1,50,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
896621,Paclitaxel,1,0,0,0,48,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
877463,Paclitaxel + Ganetespib,0,0,1,0,45,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
227881,Paclitaxel + Neratinib,1,1,0,1,49,White,Above categories not applicable AND Age < 50,Hispanic or Latino
846156,Paclitaxel + Ganetespib,0,0,1,0,44,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
683374,Paclitaxel + Neratinib,1,1,0,0,58,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
301968,Paclitaxel + AMG 386,1,0,1,0,45,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
771813,Paclitaxel,0,0,1,0,49,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
567907,Paclitaxel + Ganitumab,1,0,0,0,52,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
225836,Paclitaxel + Neratinib,0,0,0,0,70,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
983841,Paclitaxel + Ganetespib,0,0,1,1,52,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
181819,Paclitaxel,1,0,0,1,32,Black or African American,Above categories not applicable AND Age < 50,Not Hispanic or Latino
209397,Paclitaxel + Pembrolizumab,1,0,0,0,45,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
412772,Paclitaxel + Ganitumab,0,0,1,0,62,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
460776,Paclitaxel,1,0,0,1,61,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
840501,Paclitaxel + AMG 386,0,0,0,1,33,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
932200,Paclitaxel,1,0,1,0,24,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
356684,Paclitaxel + AMG 386 + Trastuzumab,1,1,1,0,51,Native Hawaiian or Pacific Islander,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
856159,Paclitaxel + Trastuzumab,1,1,0,0,46,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
299840,Paclitaxel,0,0,1,0,36,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
267306,Paclitaxel + ABT 888 + Carboplatin,0,0,1,1,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
466267,Paclitaxel + Ganetespib,0,0,1,1,51,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
934906,Paclitaxel,0,0,1,0,32,Asian;White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
129837,Paclitaxel + ABT 888 + Carboplatin,0,0,1,0,67,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
862244,Paclitaxel + Pertuzumab + Trastuzumab,0,1,0,0,60,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
455828,Paclitaxel,1,0,0,1,50,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
239061,Paclitaxel + Ganitumab,0,0,1,0,70,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
974618,Paclitaxel + AMG 386,0,0,0,1,67,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
815493,Paclitaxel + Pembrolizumab,0,0,1,1,37,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
797427,Paclitaxel + Trastuzumab,1,1,0,0,52,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
197942,Paclitaxel,0,0,0,0,34,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
254273,T-DM1 + Pertuzumab,1,1,0,0,51,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
111038,Paclitaxel + AMG 386,0,0,1,0,28,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
690089,Paclitaxel + AMG 386,0,0,0,0,43,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
597253,Paclitaxel + AMG 386,1,0,0,0,59,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
491526,Paclitaxel,1,0,0,0,71,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
598835,T-DM1 + Pertuzumab,0,1,1,0,41,American Indian or Alaska Native,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
103693,Paclitaxel + Pembrolizumab,1,0,0,0,59,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
839274,Paclitaxel + MK-2206 + Trastuzumab,1,1,1,0,68,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
136536,Paclitaxel,0,0,1,1,42,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
157463,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,44,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
570148,Paclitaxel + Neratinib,1,1,0,0,44,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
882538,Paclitaxel + Ganitumab,0,0,1,1,56,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
151230,Paclitaxel + Neratinib,1,1,0,0,45,Black or African American,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
380972,Paclitaxel + Ganetespib,1,0,0,0,28,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
666450,Paclitaxel + Neratinib,1,1,0,0,45,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
953885,T-DM1 + Pertuzumab,1,1,1,0,42,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
439489,Paclitaxel + Ganetespib,1,0,0,0,41,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
570380,Paclitaxel + Neratinib,0,0,1,0,44,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
133650,Paclitaxel + Ganetespib,1,0,1,0,54,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
502486,Paclitaxel,0,0,1,0,28,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
987914,Paclitaxel,0,0,1,0,57,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
437162,T-DM1 + Pertuzumab,1,1,0,0,45,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
255388,Paclitaxel + MK-2206 + Trastuzumab,0,1,1,1,57,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
377460,Paclitaxel + Pertuzumab + Trastuzumab,0,1,1,1,53,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
127675,Paclitaxel + Neratinib,0,0,0,0,59,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
790722,Paclitaxel + ABT 888 + Carboplatin,0,0,1,0,64,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
709559,Paclitaxel,1,0,0,0,48,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
284443,Paclitaxel + AMG 386 + Trastuzumab,1,1,0,0,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
923968,Paclitaxel + AMG 386,1,0,0,1,40,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
477816,Paclitaxel,1,0,0,0,39,Black or African American,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
298101,Paclitaxel + MK-2206 + Trastuzumab,1,1,0,0,71,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
151980,Paclitaxel + Ganetespib,1,0,1,1,46,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
115987,Paclitaxel + Ganitumab,0,0,1,0,42,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
804979,Paclitaxel + Ganitumab,1,0,0,0,47,Asian,,Not Hispanic or Latino
632408,Paclitaxel + AMG 386,1,0,1,0,65,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
105286,Paclitaxel + Ganitumab,1,0,0,0,65,White,,Not Hispanic or Latino
765773,Paclitaxel + Ganetespib,0,0,1,1,49,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
803514,Paclitaxel,1,0,0,0,55,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
202956,Paclitaxel + Neratinib,0,0,1,1,49,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
144302,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,0,52,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
362993,Paclitaxel,0,0,0,0,35,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
809649,Paclitaxel + Trastuzumab,0,1,0,1,44,Black or African American,Above categories not applicable AND Age < 50,Not Hispanic or Latino
552549,Paclitaxel + AMG 386,1,0,0,0,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
220664,Paclitaxel + Neratinib,0,0,1,1,47,Asian,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
941191,Paclitaxel + Neratinib,1,1,0,0,52,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
411950,Paclitaxel + Ganitumab,1,0,1,0,61,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
114087,Paclitaxel + Pembrolizumab,1,0,0,0,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
240432,Paclitaxel,1,0,0,0,48,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
414286,Paclitaxel + MK-2206,1,0,1,0,62,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
301289,Paclitaxel + Pembrolizumab,1,0,0,0,42,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
462605,Paclitaxel + Pertuzumab + Trastuzumab,0,1,1,1,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
697871,Paclitaxel + ABT 888 + Carboplatin,0,0,1,1,39,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
442981,Paclitaxel + Pembrolizumab,1,0,0,1,35,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
435279,Paclitaxel + Ganitumab,1,0,0,0,47,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
204939,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,1,49,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
496205,Paclitaxel + AMG 386,1,0,0,1,68,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
688955,Paclitaxel,1,0,1,0,40,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
700549,Paclitaxel + MK-2206,1,0,0,0,34,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
536253,T-DM1 + Pertuzumab,1,1,0,1,51,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
442669,Paclitaxel + Ganetespib,0,0,1,0,53,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
147139,Paclitaxel + Pembrolizumab,0,0,1,1,52,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
328160,Paclitaxel,1,0,0,0,55,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
860243,Paclitaxel + Ganetespib,1,0,1,0,47,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
228192,Paclitaxel + AMG 386,0,0,0,0,56,White,Above categories not applicable AND Age > 50,Hispanic or Latino
284593,Paclitaxel + MK-2206,0,0,1,0,32,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
248255,Paclitaxel + Ganitumab,1,0,0,0,31,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
875089,Paclitaxel + Ganitumab,0,0,1,0,42,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
771443,Paclitaxel + MK-2206 + Trastuzumab,1,1,0,0,51,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
889049,Paclitaxel + Trastuzumab,0,1,0,0,36,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
531672,Paclitaxel + AMG 386,1,0,0,0,28,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
462582,Paclitaxel,1,0,0,0,55,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
641246,Paclitaxel + Neratinib,1,1,0,1,58,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
894128,Paclitaxel + AMG 386,0,0,1,1,57,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
196064,Paclitaxel + AMG 386,1,0,1,1,50,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
578975,Paclitaxel + MK-2206,0,0,0,1,43,Black or African American,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
335091,Paclitaxel + Trastuzumab,1,1,0,1,39,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
829491,Paclitaxel + AMG 386,0,0,0,0,57,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
406190,Paclitaxel + Neratinib,0,0,1,0,54,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
781335,Paclitaxel + ABT 888 + Carboplatin,0,0,0,0,57,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
801641,Paclitaxel + MK-2206,0,0,1,0,53,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
628692,Paclitaxel + Neratinib,1,0,0,0,58,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
213913,T-DM1 + Pertuzumab,0,1,1,1,69,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
580632,Paclitaxel + Ganitumab,1,0,0,0,64,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
783578,Paclitaxel + ABT 888 + Carboplatin,0,0,1,1,48,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
414971,Paclitaxel + MK-2206,0,0,1,1,73,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
847753,Paclitaxel + Pembrolizumab,1,0,0,1,54,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
573605,Paclitaxel + MK-2206,0,0,1,0,38,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
910706,Paclitaxel + ABT 888 + Carboplatin,0,0,1,1,37,Black or African American,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
553012,Paclitaxel + Pembrolizumab,1,0,0,0,63,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
782334,Paclitaxel,1,0,0,0,46,Black or African American,Perimenopausal (6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
836114,Paclitaxel + AMG 386,1,0,1,0,48,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
944419,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,38,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
159352,Paclitaxel + MK-2206 + Trastuzumab,1,1,0,0,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
374121,Paclitaxel + ABT 888 + Carboplatin,0,0,1,0,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
573881,Paclitaxel + Neratinib,1,0,0,0,49,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
103939,Paclitaxel,1,0,0,0,51,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
676048,Paclitaxel + ABT 888 + Carboplatin,0,0,0,0,52,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
416434,Paclitaxel + MK-2206 + Trastuzumab,0,1,0,1,65,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
824512,Paclitaxel + Ganetespib,1,0,0,0,68,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
472799,Paclitaxel + Pertuzumab + Trastuzumab,0,1,1,1,63,American Indian or Alaska Native;White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
178649,Paclitaxel + Neratinib,0,0,1,1,58,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
928446,Paclitaxel + Ganitumab,1,0,0,0,39,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
245655,Paclitaxel + Neratinib,0,0,1,0,43,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
117707,Paclitaxel + Ganetespib,0,0,1,1,50,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
553141,Paclitaxel + ABT 888 + Carboplatin,1,0,1,1,70,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
382853,Paclitaxel + Trastuzumab,0,1,0,1,32,Black or African American,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
781642,Paclitaxel + Ganetespib,0,0,1,0,61,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
631337,Paclitaxel,1,0,0,0,28,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
516763,Paclitaxel + AMG 386 + Trastuzumab,0,1,1,1,50,Black or African American,Above categories not applicable AND Age > 50,Not Hispanic or Latino
685182,Paclitaxel + Pertuzumab + Trastuzumab,1,1,1,1,37,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
317641,Paclitaxel + MK-2206,0,0,1,1,28,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
587691,T-DM1 + Pertuzumab,1,1,0,1,63,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
174904,Paclitaxel + AMG 386,1,0,0,0,48,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
778020,Paclitaxel + Neratinib,1,0,1,0,54,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
695521,Paclitaxel + AMG 386,1,0,0,0,57,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
493472,Paclitaxel + Ganetespib,1,0,0,0,66,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
885590,Paclitaxel,1,0,0,0,47,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
443708,Paclitaxel + Neratinib,0,0,1,0,55,White,,Not Hispanic or Latino
622078,Paclitaxel + Neratinib,0,1,1,0,46,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
627118,Paclitaxel + Trastuzumab,0,1,0,0,44,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
916645,Paclitaxel,1,0,0,1,50,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
899692,Paclitaxel,0,0,1,1,57,Black or African American,Above categories not applicable AND Age > 50,Not Hispanic or Latino
427321,Paclitaxel + ABT 888 + Carboplatin,1,0,0,1,51,Black or African American,,Not Hispanic or Latino
581648,Paclitaxel,0,0,0,0,42,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
172366,Paclitaxel + Ganitumab,0,0,1,1,51,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
329076,Paclitaxel + AMG 386,1,0,0,0,43,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
903880,Paclitaxel + Neratinib,1,1,0,0,53,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
146987,Paclitaxel + AMG 386,1,0,1,0,53,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
913225,Paclitaxel + Neratinib,1,1,0,1,51,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
201873,Paclitaxel + Neratinib,1,1,0,1,49,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
345574,Paclitaxel + ABT 888 + Carboplatin,0,0,1,1,39,Asian,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
905264,Paclitaxel + MK-2206 + Trastuzumab,0,1,0,0,69,Black or African American,Above categories not applicable AND Age > 50,Not Hispanic or Latino
142688,Paclitaxel,0,0,1,0,45,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
655128,Paclitaxel + AMG 386,1,0,0,0,49,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
309830,Paclitaxel + MK-2206,0,0,1,0,32,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
653325,Paclitaxel + AMG 386,1,0,0,0,35,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
929980,Paclitaxel + MK-2206 + Trastuzumab,0,1,1,1,55,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
712276,Paclitaxel + MK-2206,1,0,0,1,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
966016,Paclitaxel + Ganitumab,1,0,0,1,53,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
649198,Paclitaxel + Pertuzumab + Trastuzumab,0,1,0,0,50,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
953262,Paclitaxel + Neratinib,1,0,1,0,36,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
974181,Paclitaxel + AMG 386,0,0,1,1,41,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
357017,Paclitaxel,1,0,0,0,45,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
380239,Paclitaxel + Neratinib,0,0,1,0,55,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
178815,Paclitaxel + Neratinib,1,0,0,0,39,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
299962,Paclitaxel + Ganitumab,0,0,1,0,41,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
575372,Paclitaxel + ABT 888 + Carboplatin,0,0,1,1,66,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
350331,Paclitaxel + Trastuzumab,0,1,0,0,54,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
417474,Paclitaxel + Ganitumab,0,0,1,1,63,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
527320,Paclitaxel,0,0,0,0,45,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
851488,Paclitaxel + Ganitumab,1,0,0,0,63,White,,Not Hispanic or Latino
535779,Paclitaxel + Ganitumab,0,0,1,0,39,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
127791,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,0,44,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
263143,Paclitaxel + MK-2206 + Trastuzumab,0,1,1,0,54,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
791944,Paclitaxel + Neratinib,1,1,0,0,65,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
629606,Paclitaxel + Ganitumab,0,0,1,0,42,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
209967,Paclitaxel + Ganitumab,1,0,0,0,45,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
728182,Paclitaxel + AMG 386,1,0,0,0,41,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
183831,Paclitaxel + MK-2206,1,0,0,1,49,Asian,Above categories not applicable AND Age < 50,Not Hispanic or Latino
343898,Paclitaxel + MK-2206,0,0,0,0,45,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
353318,Paclitaxel,0,0,1,0,53,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
531988,Paclitaxel + Ganitumab,0,0,1,1,36,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
963303,Paclitaxel,1,0,0,0,37,Asian;White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
631299,Paclitaxel + Ganetespib,0,0,1,0,53,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
264678,Paclitaxel,1,0,0,0,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
987995,Paclitaxel + AMG 386,1,0,0,0,56,White,Above categories not applicable AND Age > 50,Hispanic or Latino
235995,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,1,50,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
962472,Paclitaxel + AMG 386,1,0,0,0,29,Black or African American,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
624777,T-DM1 + Pertuzumab,1,1,0,0,52,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
515141,Paclitaxel + AMG 386,0,0,0,1,43,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
411684,Paclitaxel + ABT 888 + Carboplatin,0,0,1,0,39,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
637566,Paclitaxel + MK-2206,0,0,1,0,68,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
640043,Paclitaxel + Pembrolizumab,1,0,0,0,33,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
111004,Paclitaxel + Pembrolizumab,1,0,0,0,,,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
198891,Paclitaxel,1,0,0,0,61,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
830958,Paclitaxel + Pembrolizumab,1,0,0,0,55,Black or African American,Above categories not applicable AND Age > 50,Not Hispanic or Latino
824350,T-DM1 + Pertuzumab,0,1,1,1,58,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
573586,Paclitaxel + Trastuzumab,1,1,0,0,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
755914,Paclitaxel + MK-2206,0,0,1,1,47,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
316996,Paclitaxel + Neratinib,0,1,0,0,51,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
363669,Paclitaxel,1,0,0,0,60,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
190224,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,63,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
461824,Paclitaxel + ABT 888 + Carboplatin,0,0,0,0,36,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
345483,Paclitaxel + Ganitumab,0,0,1,0,50,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
479417,Paclitaxel + ABT 888 + Carboplatin,0,0,1,1,49,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
261304,Paclitaxel + Ganitumab,1,0,0,0,49,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
941926,Paclitaxel,1,0,0,0,51,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
906042,Paclitaxel,1,0,0,0,55,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
988443,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,49,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
180027,Paclitaxel + AMG 386,0,0,1,1,40,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
845663,Paclitaxel,1,0,0,0,32,Asian,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
134526,Paclitaxel + Neratinib,0,0,1,1,36,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
727804,Paclitaxel + MK-2206,0,0,1,1,43,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
623086,Paclitaxel + Neratinib,1,0,1,0,34,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
814299,Paclitaxel + Neratinib,0,1,0,1,40,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
654021,Paclitaxel,1,0,0,0,46,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
203060,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,0,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
820807,Paclitaxel + Ganitumab,1,0,0,1,50,Black or African American,Above categories not applicable AND Age < 50,Not Hispanic or Latino
211408,Paclitaxel + Neratinib,0,1,0,1,58,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
286984,Paclitaxel + MK-2206,1,0,1,0,50,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
914968,Paclitaxel + Ganetespib,0,0,1,0,30,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
289420,Paclitaxel + Ganitumab,1,0,0,0,64,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
192548,Paclitaxel + ABT 888 + Carboplatin,1,0,1,0,51,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
255078,Paclitaxel,0,0,1,0,57,White,Above categories not applicable AND Age > 50,Hispanic or Latino
515105,Paclitaxel + Neratinib,1,1,0,0,38,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
273745,Paclitaxel,1,0,0,0,48,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
374106,Paclitaxel + Neratinib,0,0,1,0,36,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
890414,Paclitaxel,0,0,0,1,55,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
604326,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,0,60,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
563856,Paclitaxel + Neratinib,0,0,1,1,40,Black or African American,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
688291,Paclitaxel + AMG 386,1,0,0,0,56,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
530095,Paclitaxel + AMG 386,1,0,0,0,45,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
705381,T-DM1 + Pertuzumab,1,1,0,1,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
636424,Paclitaxel,0,0,1,0,33,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
222135,Paclitaxel + AMG 386,1,0,0,0,53,Black or African American,Above categories not applicable AND Age > 50,Not Hispanic or Latino
349639,Paclitaxel + Neratinib,1,1,1,1,43,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
703455,Paclitaxel + Ganetespib,0,0,1,0,44,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
386664,Paclitaxel + AMG 386,1,0,0,0,63,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
651541,Paclitaxel + Neratinib,0,0,1,1,65,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
426106,Paclitaxel + MK-2206,1,0,1,0,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
981461,T-DM1 + Pertuzumab,1,1,0,0,44,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
446263,Paclitaxel + Pembrolizumab,1,0,1,1,53,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
122795,Paclitaxel + Ganitumab,0,0,0,0,45,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
396723,T-DM1 + Pertuzumab,1,1,0,0,72,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
677910,Paclitaxel + AMG 386,0,0,1,0,45,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
313672,Paclitaxel + Ganetespib,1,0,0,0,73,White,,Not Hispanic or Latino
500826,Paclitaxel + Pembrolizumab,1,0,0,0,69,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
729270,Paclitaxel + Neratinib,0,1,0,1,50,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
666147,Paclitaxel + Ganitumab,1,0,0,0,27,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
179369,Paclitaxel + MK-2206,1,0,0,0,36,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
982505,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,0,51,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
375954,Paclitaxel + MK-2206 + Trastuzumab,0,1,1,0,36,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
194024,Paclitaxel + Pembrolizumab,1,0,1,1,41,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
320538,Paclitaxel,0,0,1,0,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
152197,Paclitaxel + Pembrolizumab,0,0,1,1,59,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
637051,Paclitaxel + Ganetespib,0,0,1,0,52,White,Above categories not applicable AND Age > 50,Hispanic or Latino
697098,Paclitaxel + Neratinib,0,0,1,1,37,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
832056,Paclitaxel + Pembrolizumab,0,0,1,0,41,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
942017,Paclitaxel,1,0,1,0,44,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
266509,Paclitaxel + AMG 386,0,0,0,1,59,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
307659,Paclitaxel + Neratinib,1,1,0,0,56,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
677915,Paclitaxel,1,0,1,0,43,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
100899,Paclitaxel + Ganitumab,0,0,1,0,53,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
803677,Paclitaxel + MK-2206,0,0,1,0,53,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
233832,Paclitaxel + ABT 888 + Carboplatin,0,0,1,0,42,Black or African American,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
733276,Paclitaxel + Ganetespib,0,0,1,0,54,Black or African American,Above categories not applicable AND Age > 50,Not Hispanic or Latino
994987,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,62,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
360937,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,50,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
357034,Paclitaxel + Ganetespib,1,0,1,0,63,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
485637,Paclitaxel + Pembrolizumab,0,0,0,0,54,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
590220,Paclitaxel + MK-2206,0,0,1,1,41,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
405717,Paclitaxel,0,0,0,0,44,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
640463,Paclitaxel + ABT 888 + Carboplatin,1,0,1,1,31,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
650589,Paclitaxel + AMG 386,0,0,0,0,52,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
291515,Paclitaxel + ABT 888 + Carboplatin,0,0,1,0,44,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
955953,Paclitaxel + MK-2206 + Trastuzumab,0,1,0,1,36,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
799149,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,1,35,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
182346,Paclitaxel + Ganitumab,1,0,0,0,58,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
340186,Paclitaxel + ABT 888 + Carboplatin,0,0,0,0,54,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
324021,Paclitaxel + Pertuzumab + Trastuzumab,1,1,1,0,44,Black or African American,,Not Hispanic or Latino
943633,Paclitaxel + AMG 386,0,0,1,0,50,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
429220,Paclitaxel + Ganitumab,0,0,1,0,52,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
236470,Paclitaxel + Ganetespib,0,0,1,1,54,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
640927,Paclitaxel + Neratinib,0,0,0,0,62,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
901705,Paclitaxel,1,0,0,0,42,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
712785,Paclitaxel,0,0,1,0,50,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
109980,Paclitaxel + Neratinib,1,1,0,1,53,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
489504,Paclitaxel,0,0,1,1,47,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
845079,T-DM1 + Pertuzumab,1,1,1,1,43,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
234272,Paclitaxel + Neratinib,1,1,0,0,41,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
706418,T-DM1 + Pertuzumab,0,1,1,1,59,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
259206,Paclitaxel + ABT 888 + Carboplatin,0,0,1,0,64,White,Above categories not applicable AND Age > 50,Hispanic or Latino
149654,Paclitaxel + Pembrolizumab,1,0,0,0,,,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
904269,Paclitaxel + ABT 888 + Carboplatin,0,0,1,1,59,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
663197,Paclitaxel + Pembrolizumab,0,0,1,0,43,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
857165,Paclitaxel + Pembrolizumab,1,0,1,0,47,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
330134,Paclitaxel + Ganitumab,1,0,0,0,60,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
771151,Paclitaxel + AMG 386,0,0,1,1,45,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
646600,Paclitaxel + Ganetespib,1,0,1,0,35,White,,Not Hispanic or Latino
629371,Paclitaxel + MK-2206 + Trastuzumab,0,1,1,1,58,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
169918,Paclitaxel + AMG 386,1,0,0,0,50,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
507198,Paclitaxel,0,0,1,0,44,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
800710,Paclitaxel,0,0,1,0,29,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
570966,Paclitaxel + AMG 386 + Trastuzumab,1,1,1,0,51,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
745633,Paclitaxel + Ganitumab,1,0,0,0,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
255535,Paclitaxel + Neratinib,1,1,0,0,44,Black or African American,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
725455,Paclitaxel + Trastuzumab,0,1,1,0,49,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
698094,Paclitaxel,1,0,0,0,53,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
734997,Paclitaxel,1,0,1,0,38,White,,Not Hispanic or Latino
792181,Paclitaxel + AMG 386,0,0,1,1,60,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
934459,Paclitaxel + ABT 888 + Carboplatin,0,0,0,0,70,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
467686,Paclitaxel + Ganitumab,1,0,1,1,37,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
421829,Paclitaxel,0,0,1,0,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
644186,Paclitaxel,1,0,0,0,46,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
456432,Paclitaxel + Ganetespib,0,0,1,0,45,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
478484,Paclitaxel + Neratinib,0,0,0,0,64,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
166782,Paclitaxel + Neratinib,1,1,0,0,52,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
287961,Paclitaxel + MK-2206 + Trastuzumab,1,1,0,1,53,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
435313,Paclitaxel + ABT 888 + Carboplatin,0,0,1,0,52,Black or African American,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
202539,Paclitaxel,1,0,0,1,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
520986,Paclitaxel + MK-2206,1,0,0,1,53,Native Hawaiian or Pacific Islander,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
252748,Paclitaxel,0,0,1,1,41,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
306127,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,55,Black or African American,Above categories not applicable AND Age > 50,Not Hispanic or Latino
129973,Paclitaxel + ABT 888 + Carboplatin,0,0,1,1,35,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
959366,Paclitaxel + ABT 888 + Carboplatin,0,0,1,1,65,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
454808,Paclitaxel + Ganitumab,0,0,1,0,56,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
727255,T-DM1 + Pertuzumab,0,1,1,0,53,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
597907,Paclitaxel + AMG 386,1,0,0,0,52,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
962664,Paclitaxel,0,0,1,1,30,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
228340,Paclitaxel + Neratinib,0,1,0,0,66,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
539291,Paclitaxel + Neratinib,0,1,0,1,47,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
341238,Paclitaxel + Pembrolizumab,1,0,0,0,27,Asian;White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
759015,Paclitaxel + Neratinib,1,0,0,0,36,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
655795,Paclitaxel,1,0,1,1,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
790397,T-DM1 + Pertuzumab,1,1,0,1,33,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
572731,Paclitaxel + ABT 888 + Carboplatin,1,0,1,1,34,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
644609,Paclitaxel + Pertuzumab + Trastuzumab,0,1,1,1,67,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
459311,Paclitaxel + Ganetespib,1,0,1,0,54,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
987728,Paclitaxel + Ganitumab,0,0,1,1,56,Asian,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
572235,Paclitaxel + Neratinib,1,1,0,0,54,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
609642,Paclitaxel + MK-2206 + Trastuzumab,0,1,1,1,58,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
946927,Paclitaxel + MK-2206 + Trastuzumab,0,1,0,1,63,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
950131,Paclitaxel,1,0,0,1,42,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
311316,T-DM1 + Pertuzumab,1,1,0,0,48,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
596458,Paclitaxel + Neratinib,1,1,0,1,58,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
889721,T-DM1 + Pertuzumab,0,1,1,1,64,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
465008,Paclitaxel + Ganitumab,1,0,1,0,62,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
865416,T-DM1 + Pertuzumab,1,1,0,0,41,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
835658,Paclitaxel + Neratinib,1,0,1,1,50,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
660915,Paclitaxel + Neratinib,1,0,1,0,54,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
493519,Paclitaxel,1,0,0,0,40,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
318569,Paclitaxel + Neratinib,1,1,0,0,39,Asian,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
819622,Paclitaxel,1,0,0,0,53,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
600536,Paclitaxel + AMG 386,0,0,1,0,37,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
566011,Paclitaxel + Neratinib,0,0,1,0,59,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
138027,Paclitaxel + Ganitumab,0,0,1,0,64,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
788149,Paclitaxel + AMG 386 + Trastuzumab,1,1,0,1,57,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
318438,Paclitaxel,0,0,0,0,60,White,Perimenopausal (6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
422013,Paclitaxel + Neratinib,1,1,0,0,32,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
663467,Paclitaxel + ABT 888 + Carboplatin,1,0,1,0,45,Black or African American,,Not Hispanic or Latino
823618,Paclitaxel + AMG 386,1,0,0,0,37,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
188511,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,60,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
317131,Paclitaxel + Ganitumab,1,0,1,0,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
383456,Paclitaxel + AMG 386,1,0,0,1,50,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
573919,Paclitaxel + MK-2206 + Trastuzumab,0,1,0,0,65,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
660534,Paclitaxel + Pembrolizumab,0,0,1,1,50,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
692885,Paclitaxel + Pembrolizumab,0,0,1,0,40,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
834418,Paclitaxel,1,0,0,0,59,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
602943,Paclitaxel,0,0,1,1,38,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
378401,Paclitaxel + AMG 386,0,0,0,1,61,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
123660,Paclitaxel + Trastuzumab,0,1,0,0,71,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
859699,Paclitaxel + Trastuzumab,1,1,0,1,53,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
188091,Paclitaxel + Neratinib,0,1,0,1,50,Black or African American,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
736721,Paclitaxel + AMG 386,1,0,1,0,41,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
233191,Paclitaxel,0,0,1,0,42,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
111674,Paclitaxel + ABT 888 + Carboplatin,0,0,0,1,30,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
407539,Paclitaxel + Ganitumab,1,0,0,0,35,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
511851,Paclitaxel + Ganitumab,1,0,0,0,48,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
895653,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,1,43,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
128051,T-DM1 + Pertuzumab,1,1,0,0,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
824234,Paclitaxel + Trastuzumab,1,1,0,1,30,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
283070,Paclitaxel + AMG 386,0,0,1,0,68,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
229144,Paclitaxel,1,0,0,0,54,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
424541,Paclitaxel,1,0,0,0,58,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
542392,Paclitaxel + Ganitumab,0,0,1,0,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
812089,Paclitaxel + Neratinib,0,0,0,0,58,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
749097,Paclitaxel,1,0,0,0,46,Black or African American,Above categories not applicable AND Age < 50,Not Hispanic or Latino
437968,Paclitaxel + Neratinib,1,1,0,0,60,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
460812,Paclitaxel + Ganetespib,1,0,1,0,50,Black or African American,Above categories not applicable AND Age > 50,Not Hispanic or Latino
728714,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,50,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
413961,Paclitaxel + MK-2206,0,0,1,0,49,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
395379,Paclitaxel,1,0,0,0,36,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
294176,Paclitaxel + Neratinib,0,0,1,1,56,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
130580,Paclitaxel + Ganitumab,0,0,1,1,56,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
375342,Paclitaxel + Ganitumab,0,0,1,0,38,White,Above categories not applicable AND Age < 50,Hispanic or Latino
503034,Paclitaxel + Pertuzumab + Trastuzumab,0,1,0,0,42,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
490023,Paclitaxel + MK-2206 + Trastuzumab,0,1,1,1,34,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
299364,Paclitaxel,0,0,1,0,40,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
303947,Paclitaxel + Neratinib,0,1,1,1,61,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
766967,Paclitaxel + Ganitumab,1,0,0,1,44,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
726381,Paclitaxel + Trastuzumab,1,1,0,0,63,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
841336,Paclitaxel,1,0,0,0,47,Black or African American,,Not Hispanic or Latino
589502,Paclitaxel + Ganetespib,1,0,0,1,67,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
462581,Paclitaxel + Ganetespib,0,0,1,0,69,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
940186,Paclitaxel + Ganetespib,1,0,0,1,44,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
592535,Paclitaxel + ABT 888 + Carboplatin,1,0,0,0,44,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
443444,Paclitaxel + Neratinib,0,1,1,0,61,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
492612,Paclitaxel,0,0,1,0,37,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
787415,Paclitaxel + AMG 386,0,0,1,0,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
885871,Paclitaxel,0,0,1,0,41,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
728149,T-DM1 + Pertuzumab,1,1,0,0,46,White,,Not Hispanic or Latino
962827,Paclitaxel + Ganitumab,1,0,0,0,37,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
995480,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,0,46,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
528833,Paclitaxel + AMG 386 + Trastuzumab,1,1,0,1,61,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
775346,Paclitaxel,1,0,0,0,35,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
515565,Paclitaxel,0,0,1,0,59,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
442637,Paclitaxel + Trastuzumab,0,1,0,0,56,Asian,Perimenopausal (6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
408692,Paclitaxel,0,0,1,1,25,Asian;White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
497010,Paclitaxel + Pembrolizumab,0,0,1,1,31,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
805136,Paclitaxel + AMG 386 + Trastuzumab,0,1,1,0,52,Black or African American,,Not Hispanic or Latino
238790,Paclitaxel,0,0,1,0,44,Black or African American,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
327142,Paclitaxel + Neratinib,1,0,0,0,59,Black or African American,Above categories not applicable AND Age > 50,Not Hispanic or Latino
132463,Paclitaxel + MK-2206 + Trastuzumab,1,1,1,1,64,Asian,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
726940,Paclitaxel,0,0,0,0,51,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
262131,Paclitaxel + ABT 888 + Carboplatin,0,0,1,0,41,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
792412,Paclitaxel + Pembrolizumab,0,0,1,0,32,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
169536,Paclitaxel + Neratinib,1,1,0,0,25,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
517870,Paclitaxel,0,0,1,0,52,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
652480,Paclitaxel + AMG 386,0,0,1,0,36,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
151481,Paclitaxel,0,0,0,0,54,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
199115,Paclitaxel + AMG 386,1,0,0,0,61,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
630758,Paclitaxel + ABT 888 + Carboplatin,0,0,1,0,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
783764,Paclitaxel + Ganitumab,1,0,0,0,54,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
752372,Paclitaxel,1,0,0,0,59,White,Above categories not applicable AND Age < 50,Hispanic or Latino
549172,Paclitaxel,0,0,0,0,45,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
174903,Paclitaxel + AMG 386,1,0,0,0,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
808714,Paclitaxel,0,0,1,0,69,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
928815,Paclitaxel + AMG 386,0,0,1,0,38,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
241705,Paclitaxel + Ganitumab,1,0,0,0,49,Black or African American,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
148357,Paclitaxel + Ganitumab,1,0,0,0,55,Black or African American,Above categories not applicable AND Age > 50,Not Hispanic or Latino
680881,Paclitaxel + MK-2206,1,0,1,0,33,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
591810,Paclitaxel + MK-2206,1,0,0,1,35,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
790070,Paclitaxel + Neratinib,1,1,0,0,44,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
128675,Paclitaxel,1,0,1,1,47,White,Perimenopausal(6-12 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
889225,Paclitaxel + AMG 386,1,0,0,0,46,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
411008,Paclitaxel + AMG 386,0,0,1,0,49,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
723918,Paclitaxel + Neratinib,1,1,0,1,35,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
742477,Paclitaxel + Trastuzumab,1,1,0,0,44,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
579881,Paclitaxel,1,0,0,0,32,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
162562,Paclitaxel + Trastuzumab,0,1,1,1,61,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
687288,T-DM1 + Pertuzumab,0,1,1,1,57,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
120422,Paclitaxel + Ganitumab,1,0,1,1,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
203254,Paclitaxel + MK-2206,0,0,1,0,25,Asian,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
898618,Paclitaxel + Ganitumab,1,0,0,0,54,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
628823,Paclitaxel + Ganitumab,0,0,1,0,42,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
423619,Paclitaxel + Neratinib,0,0,1,1,53,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
349330,Paclitaxel + AMG 386,0,0,1,1,50,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
524170,Paclitaxel + Ganitumab,1,0,0,0,38,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
240957,Paclitaxel + AMG 386,1,0,0,0,46,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
584561,Paclitaxel + Pertuzumab + Trastuzumab,0,1,1,1,39,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
421917,Paclitaxel,0,0,1,0,41,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
115638,Paclitaxel + Ganitumab,0,0,1,0,34,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
154293,Paclitaxel + Neratinib,1,1,0,0,52,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
746731,Paclitaxel + ABT 888 + Carboplatin,0,0,1,1,46,Black or African American,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
282082,Paclitaxel,0,0,1,1,,,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
433144,Paclitaxel,0,0,0,1,59,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
883886,Paclitaxel + Neratinib,0,0,1,0,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
928170,Paclitaxel + Ganitumab,1,0,0,0,67,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
223526,Paclitaxel + Neratinib,1,0,0,0,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
520471,Paclitaxel + Ganitumab,1,0,1,1,35,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
172283,Paclitaxel + Neratinib,0,0,1,0,48,Black or African American,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
720065,Paclitaxel + Trastuzumab,1,1,0,0,55,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
478655,Paclitaxel + Pembrolizumab,0,0,1,1,52,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
451482,Paclitaxel + AMG 386,1,0,0,0,47,Black or African American,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
223030,Paclitaxel + AMG 386,1,0,0,0,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
586091,Paclitaxel + Pembrolizumab,1,0,1,1,44,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
417654,Paclitaxel + Neratinib,1,0,0,0,68,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
234723,Paclitaxel + AMG 386,0,0,1,0,37,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
602451,Paclitaxel + Ganetespib,1,0,1,0,47,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
883696,Paclitaxel + ABT 888 + Carboplatin,1,0,1,0,27,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
970839,Paclitaxel,1,0,1,0,58,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
507249,Paclitaxel + Pertuzumab + Trastuzumab,1,1,0,0,37,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
724293,T-DM1 + Pertuzumab,1,1,0,1,41,White,,Not Hispanic or Latino
117424,Paclitaxel + Neratinib,0,0,1,1,33,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
793684,Paclitaxel + Ganetespib,0,0,1,0,48,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
380769,Paclitaxel + ABT 888 + Carboplatin,0,0,1,1,40,Black or African American,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
572444,Paclitaxel + Neratinib,1,0,0,0,54,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Hispanic or Latino
796558,Paclitaxel,0,0,0,0,38,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
925691,Paclitaxel + Neratinib,0,1,0,0,58,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
414256,Paclitaxel + Ganetespib,1,0,0,0,38,Asian,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
765671,Paclitaxel + AMG 386,0,0,0,1,41,Black or African American,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
990443,Paclitaxel + Pembrolizumab,1,0,0,0,53,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
384830,Paclitaxel + MK-2206 + Trastuzumab,1,1,0,0,37,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
836983,Paclitaxel + Neratinib,1,1,0,1,54,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
586207,Paclitaxel + AMG 386,0,0,1,1,45,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
559021,Paclitaxel + Ganitumab,1,0,1,1,34,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
746265,Paclitaxel + Neratinib,1,0,0,0,35,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
962153,Paclitaxel + AMG 386 + Trastuzumab,1,1,1,0,55,White,,Hispanic or Latino
559263,Paclitaxel,0,0,1,0,64,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
287300,Paclitaxel + Neratinib,1,1,0,1,45,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
711476,Paclitaxel,1,0,0,1,47,White,Above categories not applicable AND Age < 50,Not Hispanic or Latino
944536,Paclitaxel + Neratinib,0,1,0,1,58,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
361701,Paclitaxel + MK-2206,1,0,0,0,49,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
112606,Paclitaxel + Trastuzumab,1,1,0,0,57,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
924071,Paclitaxel + AMG 386,1,0,0,0,57,White,Above categories not applicable AND Age > 50,Not Hispanic or Latino
598798,Paclitaxel + ABT 888 + Carboplatin,1,0,1,0,46,White,Premenopausal(< 6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Not Hispanic or Latino
231633,Paclitaxel + Pembrolizumab,0,0,1,1,53,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
892390,Paclitaxel + Pembrolizumab,0,0,1,1,59,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
666715,Paclitaxel + Ganetespib,1,0,0,0,32,White,Premenopausal(<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),Hispanic or Latino
241998,Paclitaxel,1,0,0,0,54,Black or African American,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
960963,Paclitaxel + MK-2206 + Trastuzumab,1,1,0,0,56,White,Postmenopausal (prior bilateral ovariectomy OR > 12 months since LMP with no prior hysterectomy),Not Hispanic or Latino
